Skip to content
All tests

Your test, explained

4 min read

Estrogens, Total Blood Test: Comprehensive Estrogenic Load Assessment

A quantitative measurement of the sum of circulating Estrone (E1), Estradiol (E2), and Estriol (E3). It is utilized to assess overall estrogenic status, monitor menopause transition, and evaluate gynecomastia in males.

At a glance

Start with the details.

A price isn’t listed yet. Explore the guide below.

Sample
Blood (Serum)
Typical turnaround
3 - 5 days
Before your appointment

Your options, side by side

Compare retailer prices.

Find a listing that fits your needs. Review the details, then order with the retailer.

0 listings

No retailer listings yet.

Read the test guide or explore other tests in the directory.

Explore tests

Prices shown are listed test prices, not checkout totals. Expand a listing for supplied fees and its observation date. Check included measurements, collection requirements, and the performing lab before ordering.

Understand before you decide

The test, explained.

Overview

Total Estrogen is the cumulative molecular footprint of your body's primary female steroid hormones. In advanced clinical biology, it is recognized as the essential 'high-level' diagnostic for mapping the female reproductive axis and male hormonal balance.

Produced primarily in the ovaries, placenta, and adrenal glands—and through the peripheral aromatization of fat—total estrogens represent the combined concentrations of Estrone (E1), Estradiol (E2), and Estriol (E3). While each subtype has specific roles, the Total Estrogen test provides a definitive overview of your systemic estrogenic activity. It dictates bone mineral density, governs the menstrual cycle, and influences cardiovascular health. As a senior internal medicine specialist, I utilize this panel to rapidly identify overt hormonal excess or deficiency, providing the foundational data needed to fine-tune hormone replacement therapy (HRT) and investigate complex fertility challenges.

About this test

Advanced Clinical Interpretation of Total Estrogens

To extract true clinical utility from this biomarker, it must be viewed as the net result of endocrine production and hepatic metabolic clearance.

1. The Three-Part Estrogen Profile
  • The Combined Force: This test does not distinguish between individual types but sums them. Estrone (E1) is the postmenopausal leader; Estradiol (E2) is the potent reproductive engine; Estriol (E3) is the dominant form during pregnancy. Measuring them together allows for a broad screening of the total hormone load on estrogen receptors in the breast, uterus, and brain.

2. Ovulation Timing and Fertility Reserve
  • Tracking the Surge: In the follicular phase of the menstrual cycle, total estrogens rise steadily. A significant peak indicates the impending Luteinizing Hormone (LH) surge required for ovulation. If total estrogens remain chronically low despite high FSH, it provides definitive evidence of diminished ovarian reserve or impending premature ovarian failure.

3. Male Estrogen Excess (Aromatization)
  • The Testosterone Balance: In men, high levels of total estrogen are rarely produced directly; they result from the conversion of testosterone via the enzyme aromatase, primarily in belly fat. Elevated total estrogen in males is a primary driver of gynecomastia (breast tissue growth), erectile dysfunction, and increased risk of cardiovascular events. Monitoring this total load is critical for men on Testosterone Replacement Therapy (TRT).

When to discuss this test

You should prioritize this metabolic evaluation when:

  • You are experiencing perimenopausal symptoms such as night sweats, hot flashes, or unexplained mood disturbances.
  • You are a male experiencing unexplained weight gain in the chest area (gynecomastia) or a sudden decrease in libido despite normal testosterone.
  • You are tracking ovulation for pregnancy planning and need to verify the estrogenic rise.
  • You have been diagnosed with early-onset Osteoporosis or Osteopenia and need to evaluate if estrogen deficiency is driving bone mineral loss.

Who may benefit

This test is an absolute necessity for women navigating the menopausal transition, individuals monitoring the safety of bioidentical hormone replacement therapy (BHRT), men investigating hormonal drivers of infertility, and patients tracking antiestrogen treatments.

How this test is used

  • Ovarian Insufficiency and Menopause
  • Hyperestrogenism (Estrogen Dominance)
  • Gynecomastia in Males
  • Estrogen-Producing Tumors (Ovarian or Adrenal)

Before your appointment

Plan your visit.

Fasting
Follow retailer guidance
Collection timing
Morning collection preferred

How to prepare

  • Strict Fasting (10-12 Hours): While some conventional labs do not mandate fasting, precision endocrine testing requires a clean metabolic baseline. Postprandial lipemia (fats in the blood after a meal) can interfere with the optical clarity of immunoassay readings. A 10-12 hour water-only fast ensures an uncorrupted sample.
  • Cycle Day Documentation: For menstruating women, you must document the day of your cycle. Estrogen fluctuates from ~15 pg/mL post-menses to >300 pg/mL pre-ovulation. Without knowing the cycle day, the result is clinically uninterpretable.
  • Medication and Supplement Washout: Stop taking high-dose Biotin (Vitamin B7) at least 72 hours prior, as it creates significant interference in hormone assays. Disclose all use of oral contraceptives, HRT, or selective estrogen receptor modulators (SERMs).

Important considerations

The Radioisotope Interference: If you have recently undergone a diagnostic medical scan involving radioisotopes (such as a bone scan or certain heart scans), you must wait at least 7 days before drawing blood for this test. These isotopes can cause massive analytical interference, leading to completely invalid results.

Follow the instructions from your retailer and clinician. Information on this page is educational and does not replace individual medical advice.

See what to expect

Sample reports & resources.

Published examples and supporting files for this test.

No sample files are published for this test yet.

Looking for your own results? Open your reports dashboard

For a closer look

Sources & further reading.

Further reading

2025–2026 Clinical Breakthroughs:

  • Estrogen and Neuro-Immunity: A landmark 2025 study published in Nature Reviews Endocrinology established that total estrogen levels in a specific 'goldilocks' range are required to prevent microglial activation in the brain. Low total estrogen was linked to accelerated 'neuro-inflammaging,' providing a biochemical basis for perimenopausal brain fog.
  • PCOS Subtyping: 2025 clinical guidelines now utilize the Total Estrogen-to-Progesterone ratio as a primary metric for phenotyping Polycystic Ovary Syndrome (PCOS). High total estrogen relative to progesterone is now a recognized driver of endometrial hyperplasia in these patients.
  • Biotin Interference Update: 2026 laboratory standards have identified that 'Total Estrogen' immunoassays are among the most sensitive to Biotin interference. Over 12% of 'abnormal' results in 2025 were traced back to high-dose beauty supplements, reinforcing the 72-hour washout mandate.

Sources